Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Vi Partners Leads Series A Financing for Somagenetix AG to Advance Gene Therapy for Chronic Granulomatous Disease (CGD)

Oct 08, 2024•over 1 year ago

Contract Type

partnership

ZurichBiotechnology

Description

Somagenetix AG has secured CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD). The funds will enable Somagenetix to advance its leading gene therapy-candidate, SGX-001, into a clinical trial for the treatment of p47 Chronic Granulomatous Disease (CGD).

Company Information

Company

Somagenetix AG

Location

Zurich, Zurich, Switzerland

About

Somagenetix AG is a pioneering biotech company dedicated to revolutionizing gene therapy for phagocyte disorders.

Predictive Intelligence
Strategic

ML-powered predictions for Somagenetix AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.